CCCC — C4 Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for C4 Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	372	309	276	254	245
Net Total Accounts Receivable
Net Total Receivables	4.48	5.72	1.47	11.8	3.1
Prepaid Expenses
Total Current Assets	381	326	288	271	258
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	16.6	35.1	77.5	71.1	63.4
Long Term Investments
Other Long Term Assets
Total Assets	400	507	431	376	350
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	43.9	51.2	44.5	42.8	45.2
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	119	117	142	130	134
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	281	390	289	246	216
Total Liabilities & Shareholders' Equity	400	507	431	376	350
Total Common Shares Outstanding